FdaApplication

ANDA 091415

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMACEUTICALS LTD
application_typeANDA
approval_date2011-10-25

Products (4)

ProductActive ingredientStrengthDosage form
OLANZAPINEOLANZAPINE10MGTABLET, ORALLY DISINTEGRATING;ORAL
OLANZAPINEOLANZAPINE15MGTABLET, ORALLY DISINTEGRATING;ORAL
OLANZAPINEOLANZAPINE5MGTABLET, ORALLY DISINTEGRATING;ORAL
OLANZAPINEOLANZAPINE20MGTABLET, ORALLY DISINTEGRATING;ORAL

4 products